A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
about
CD8(+) T-Cells as Immune Regulators of Multiple SclerosisFollicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal ModelsRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityHumoral-targeted immunotherapies in multiple sclerosisVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Role of regulatory b cells in neuroimmunologic disordersHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairDifferential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model.Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.Inflammatory cytokines and physical activity in multiple sclerosisCirculating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.Ischemic transient neurological events identified by immune response to cerebral ischemia.What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitisPathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune EncephalomyelitisRole of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis.Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation.Activation of human B cells negatively regulates TGF-β1 production.Regulatory B cells in autoimmune diseases.Teriflunomide and its mechanism of action in multiple sclerosis.Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.Novel monoclonal antibodies for therapy of multiple sclerosis.IL-10-independent regulatory B-cell subsets and mechanisms of action.B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.B Cell Therapy for Multiple Sclerosis: Entering an Era.Regulatory B cells in Experimental Stroke.Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice.ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
P2860
Q26772339-2008C6F3-D834-4407-AD53-AD5C9B864100Q26795577-B5871BDB-C32F-4119-9DB1-B78A7957B316Q26800155-413A1742-41E7-483A-802A-871A497139B8Q26865971-3B5BE8F6-4A26-4F7F-93AB-4916E47DD4ADQ27015811-FFEF47E3-A34A-4809-8CC6-C296D10989BCQ28077219-D7BA34D8-85A6-4F06-8C72-B01B13F56383Q28078211-F13931D2-2CAB-4F2E-B07C-D81EF0A61224Q34072824-E2AAD53C-6740-4EBB-B090-0E34ACD04C7AQ34687561-66D0E79F-7823-420A-AC6B-CE9DD3244065Q35109981-6C3BC578-8995-43B4-8EC6-6B0477F4DF13Q35731510-61916B02-C72A-4D2A-A42A-E37F4A5233BEQ35891452-02A867C0-DF57-4633-927A-5C7A602574F5Q36396476-C3A37B0B-4981-4112-9D6B-DC5DE48A7295Q36778684-EB1967F6-0936-4540-8ECB-C116B2738281Q36803471-3031283F-53AC-4FDE-B180-6D5DD79AF272Q36971195-12379FBA-E7ED-4B48-BC11-68F3FF17CAC4Q37050039-C793F647-4A25-4320-91D7-8A7AFD5443B4Q37504971-AE8178A1-B2E5-452C-87E8-E6B6EF9D6BC5Q37593519-D0E3E129-8874-44ED-A71D-D7C6F768BD4DQ37729359-3D9D99A7-EB3B-456B-8724-3F4D78E2A9D6Q37730005-652FA8D4-6A04-47ED-9EFC-0DBCFA6D775AQ37990779-15A35FFE-CA40-4F79-9D18-DA5A3A6B10A6Q38191996-0F0A38A9-9528-4C91-98D4-CABA54CBA355Q38497062-D2C55A91-DE8B-47A7-9602-2256BF129E5EQ38961202-FF030914-6966-45EA-816D-7D8B824F7799Q40098910-0F895443-ED33-4B36-BCA3-2CCF99C5AC52Q41820142-7A3ADA6C-1DD7-4BB4-A011-67205375C645Q42568871-3FF47FD9-AF8C-4DB6-B0A3-767882736D46Q46583404-D6B7D39D-A215-4CF0-AD74-CC1561E8C6E2Q47875435-352EC06B-C8BD-4A48-87A9-5A384D20C7FEQ47948774-69C1741A-171F-42F3-BD1B-E751F67E538AQ49191070-82BF322C-B6FA-4187-8931-BFBF3A11C3B3Q58555322-79047DA3-9AA8-401E-B27D-B2A0459D4E76
P2860
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A case for regulatory B cells ...... elitis and multiple sclerosis.
@en
A case for regulatory B cells ...... elitis and multiple sclerosis.
@nl
type
label
A case for regulatory B cells ...... elitis and multiple sclerosis.
@en
A case for regulatory B cells ...... elitis and multiple sclerosis.
@nl
prefLabel
A case for regulatory B cells ...... elitis and multiple sclerosis.
@en
A case for regulatory B cells ...... elitis and multiple sclerosis.
@nl
P2093
P2860
P921
P1476
A case for regulatory B cells ...... elitis and multiple sclerosis.
@en
P2093
Bonnie N Dittel
Monica K Mann
Sreemanti Basu
P2860
P356
10.1016/J.JNEUROIM.2010.10.037
P50
P577
2010-12-10T00:00:00Z
2011-01-01T00:00:00Z